Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial102

File Visits

Downloads
7415-31389.pdf36

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial29

Number of downloads in the range

Downloads
7415-31389.pdf13

Views

Views
November 20254
December 20250
January 202610
February 20260
March 20268
April 20267
May 20260
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • November 2025
    4
  • December 2025
    5
  • January 2026
    0
  • February 2026
    0
  • March 2026
    1
  • April 2026
    3
  • May 2026
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Argentina1
Brazil1
Chile1
China1
Colombia1
Cyprus1
Finland1
Kenya1
Morocco1
 

Top countries by downloads

Downloads
United States5
Colombia1
Finland1
 

Top cities views

Views
San Jose10
Council Bluffs4
Los Angeles2
Adıyaman1
Bogotá1
Córdoba1
Houston1
Khouribga1
Lappeenranta1
Nairobi1
 

Top cities by downloads

Downloads
Bogotá1
Lappeenranta1